Cargando…

Phase I study of 21 days continuous infusion with vindesine.

Detalles Bibliográficos
Autores principales: de Vries, E. G., Smit, E. F., Vendrig, D. E., Holthuis, J. J., Mulder, N. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247064/
https://www.ncbi.nlm.nih.gov/pubmed/2930717
_version_ 1782150901735096320
author de Vries, E. G.
Smit, E. F.
Vendrig, D. E.
Holthuis, J. J.
Mulder, N. H.
author_facet de Vries, E. G.
Smit, E. F.
Vendrig, D. E.
Holthuis, J. J.
Mulder, N. H.
author_sort de Vries, E. G.
collection PubMed
description
format Text
id pubmed-2247064
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22470642009-09-10 Phase I study of 21 days continuous infusion with vindesine. de Vries, E. G. Smit, E. F. Vendrig, D. E. Holthuis, J. J. Mulder, N. H. Br J Cancer Research Article Nature Publishing Group 1989-03 /pmc/articles/PMC2247064/ /pubmed/2930717 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
de Vries, E. G.
Smit, E. F.
Vendrig, D. E.
Holthuis, J. J.
Mulder, N. H.
Phase I study of 21 days continuous infusion with vindesine.
title Phase I study of 21 days continuous infusion with vindesine.
title_full Phase I study of 21 days continuous infusion with vindesine.
title_fullStr Phase I study of 21 days continuous infusion with vindesine.
title_full_unstemmed Phase I study of 21 days continuous infusion with vindesine.
title_short Phase I study of 21 days continuous infusion with vindesine.
title_sort phase i study of 21 days continuous infusion with vindesine.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247064/
https://www.ncbi.nlm.nih.gov/pubmed/2930717
work_keys_str_mv AT devrieseg phaseistudyof21dayscontinuousinfusionwithvindesine
AT smitef phaseistudyof21dayscontinuousinfusionwithvindesine
AT vendrigde phaseistudyof21dayscontinuousinfusionwithvindesine
AT holthuisjj phaseistudyof21dayscontinuousinfusionwithvindesine
AT muldernh phaseistudyof21dayscontinuousinfusionwithvindesine